Although in this study we focused primarily on the role of ELK3 in regulating mitochondrial dynamics to explain the chemosensitivity of TNBC cells to CDDP, we do not rule out the possibility that ELK3 also employs alternative mechanisms to regulate the response of cancer cells to chemotherapy. This evidence concerns the gene ELK3 and cancer.